Eric Duncavage
Eric Duncavage
Professor of Pathology and Immunology, Washington University School of Medicine
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology …
MM Li, M Datto, EJ Duncavage, S Kulkarni, NI Lindeman, S Roy, ...
The Journal of molecular diagnostics 19 (1), 4-23, 2017
5882017
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
4842016
Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
2762015
Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo
CL Shirai, JN Ley, BS White, S Kim, J Tibbitts, J Shao, M Ndonwi, ...
Cancer cell 27 (5), 631-643, 2015
2032015
Validation of a next-generation sequencing assay for clinical molecular oncology
CE Cottrell, H Al-Kateb, AJ Bredemeyer, EJ Duncavage, DH Spencer, ...
The Journal of molecular diagnostics 16 (1), 89-105, 2014
1642014
Clinical next‐generation sequencing in patients with non–small cell lung cancer
IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ...
Cancer 121 (4), 631-639, 2015
1602015
Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens
DH Spencer, JK Sehn, HJ Abel, MA Watson, JD Pfeifer, EJ Duncavage
The Journal of molecular diagnostics 15 (5), 623-633, 2013
1482013
Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches
HJ Abel, EJ Duncavage
Cancer genetics 206 (12), 432-440, 2013
1312013
Arf induces p53-dependent and-independent antiproliferative genes
ML Kuo, EJ Duncavage, R Mathew, W Den Besten, D Pei, D Naeve, ...
Cancer Research 63 (5), 1046-1053, 2003
1302003
Immune escape of relapsed AML cells after allogeneic transplantation
MJ Christopher, AA Petti, MP Rettig, CA Miller, E Chendamarai, ...
New England Journal of Medicine 379 (24), 2330-2341, 2018
1272018
Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma
EJ Duncavage, BA Zehnbauer, JD Pfeifer
Modern Pathology 22 (4), 516-521, 2009
1262009
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
J Hudson, E Duncavage, A Tamburrino, P Salerno, L Xi, M Raffeld, ...
Experimental and molecular pathology 95 (1), 62-67, 2013
1222013
Performance of common analysis methods for detecting low-frequency single nucleotide variants in targeted next-generation sequence data
DH Spencer, M Tyagi, F Vallania, AJ Bredemeyer, JD Pfeifer, RD Mitra, ...
The Journal of Molecular Diagnostics 16 (1), 75-88, 2014
1142014
Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data
DH Spencer, HJ Abel, CM Lockwood, JE Payton, P Szankasi, TW Kelley, ...
The Journal of molecular diagnostics 15 (1), 81-93, 2013
1082013
Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue
EJ Duncavage, V Magrini, N Becker, JR Armstrong, RT Demeter, T Wylie, ...
The Journal of molecular diagnostics 13 (3), 325-333, 2011
962011
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
TN Wong, CA Miller, MRM Jotte, N Bagegni, JD Baty, AP Schmidt, ...
Nature communications 9 (1), 1-10, 2018
892018
Targeted next‐generation sequencing using fine‐needle aspirates from adenocarcinomas of the lung
HE Karnes, EJ Duncavage, CT Bernadt
Cancer cytopathology 122 (2), 104-113, 2014
852014
Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia
EJ Duncavage, HJ Abel, P Szankasi, TW Kelley, JD Pfeifer
Modern pathology 25 (6), 795-804, 2012
802012
Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer
E Duncavage, B Goodgame, A Sezhiyan, R Govindan, J Pfeifer
Journal of Thoracic Oncology 5 (11), 1755-1763, 2010
772010
MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors
KE Schwetye, JD Pfeifer, EJ Duncavage
Human pathology 45 (1), 65-70, 2014
702014
The system can't perform the operation now. Try again later.
Articles 1–20